USPTO 2015–2025 USPTO PatentsView US Corporation

Orexigen Therapeutics, Inc.

USPTO PatentsView assignee record - 8 granted patents across 7 technology areas, active 2015–2017. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

14.6

Avg claims per patent

-100%

5-year filing velocity

The verdict

Orexigen holds 8 US patents across 7 technology areas, rank #32,761 of 50,000 tracked assignees.

#32,761
of 50,000 US assignees by volume: Top 82%
by Innovation Score (25.7/100): 14.6
avg claims per patent: -100%
filing velocity, last 5 yrs

Portfolio overview

Orexigen Therapeutics, Inc. has been granted 8 US utility patents between 2015 and 2017, placing Orexigen Therapeutics, Inc. at rank #32,761 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.6 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Orexigen Therapeutics, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Orexigen sits between Optofluidics Inc. (8 patents, rank #32,757) and Orthodyne Electronics Corporation (8 patents, rank #32,765) - the closest US assignees by grant volume. The composite Innovation Score of 25.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 8 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Orexigen Therapeutics, Inc.'s 14.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Orexigen Therapeutics, Inc. against peers pursuing similar technology classes.

Optofluidics

8
Orbital Composites

8
Orbray

8
Orchid Exchange

8
Orgenesis

8
Orth Consulting

8
Ortho Development

8
Orthodyne

8
Orexigen Therapeu… ◀

8

What this shows Orexigen holds 8 patents at rank #32,761, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Orexigen

By rank, the assignees closest to #32,761 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Orexigen's primary technology class.

Orexigen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

26 Top 82% higher than 18% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Orexigen Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	50.0%
2016	2	25.0%
2017	2	25.0%

Which technologies does Orexigen Therapeutics, Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 8

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 7

A61J - CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 1

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 1

G01G - WEIGHING 1

G09B - EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS 1

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 1

Top 7 of 7 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#32,761

Across all tracked assignees

Innovation Score

25.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Orexigen Therapeutics, Inc. hold?

Orexigen Therapeutics, Inc. holds 8 US granted patents filed between 2015 and 2017, spanning 7 technology areas.

What is Orexigen Therapeutics, Inc.'s Innovation Score?

Orexigen Therapeutics, Inc. has an Innovation Score of 25.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Orexigen Therapeutics, Inc. focus on?

Orexigen Therapeutics, Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 8 patents. The company has filed patents in 7 CPC subclasses total.

Is Orexigen Therapeutics, Inc.'s patent filing rate increasing or decreasing?

Orexigen Therapeutics, Inc.'s recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Orexigen Therapeutics, Inc.'s patents?

Orexigen Therapeutics, Inc.'s patents average 14.6 claims each. This falls within the standard range, providing solid legal coverage.

How is the Orexigen Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Orexigen's 8 grants land it in the top 82% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Orexigen ranks #32,761 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.